Results 161 to 170 of about 2,428 (197)

Activation of Trpv4 Reduces the Hyperproliferative Phenotype of Cystic Cholangiocytes From an Animal Model of ARPKD

open access: yesGastroenterology, 2010
BACKGROUND & AIMS: In polycystic liver diseases, cyst formation involves cholangiocyte hyperproliferation. In polycystic kidney (PCK) rats, an animal model of autosomal-recessive polycystic kidney disease (ARPKD), decreased intracellular calcium [Ca(2+)]
Anatoliy Masyuk   +2 more
exaly   +1 more source

Neonatal ascites in autosomal recessive polycystic kidney disease (ARPKD)

Clinical Nephrology, 2015
Neonatal ascites is a rare entity, which is usually biliary, urinary, or chylous. Congenital hepatic fibrosis as part of the manifestations of autosomal recessive polycystic kidney disease (ARPKD) is usually a histological adjunct to the diagnosis of this mainly clinically renal entity in the neonatal period.
Galina, Ling   +4 more
openaire   +2 more sources

Molecular Basis of Autosomal Recessive Polycystic Kidney Disease (ARPKD)

Advances in Anatomic Pathology, 2008
Autosomal recessive polycystic kidney disease (ARPKD) is a serious genetic disease characterized by cystic changes in the collecting ducts of the kidney and bile ducts within the liver. The gene for ARPKD (PKHD1) is located on chromosome 6p12 and encodes a protein called fibrocystin/polyductin (FPC), 1 of many proteins that are normally present at the ...
Lulu, Al-Bhalal, Mohammed, Akhtar
openaire   +2 more sources

Remodeling of the Purinergic Receptors Profile in the ARPKD Cystic Epithelia

The FASEB Journal, 2016
Polycystic kidney diseases (PKD) are a group of inherited nephropathies marked with the formation of fluid‐filled cysts along the nephron. Autosomal Recessive PKD (ARPKD) has an incidence of approximately 1 in 20,000 live births; infants with ARPKD that survive beyond the perinatal period develop chronic renal failure by ...
Daria Ilatovskaya   +4 more
openaire   +1 more source

PKHD1mutations in autosomal recessive polycystic kidney disease (ARPKD)

Human Mutation, 2004
Autosomal recessive polycystic kidney disease (ARPKD) is an important cause of childhood renal- and liver-related morbidity and mortality. The clinical spectrum is widely variable. About 30 to 50% of affected individuals die in the neonatal period, while others survive into adulthood.
Bergmann, C.   +18 more
openaire   +3 more sources

Autosomal-rezessive polyzystische Nierenerkrankung (ARPKD)

Der Nephrologe, 2022
Kathrin Burgmaier, Max Christoph Liebau
openaire   +1 more source

A Single-Center Experience of ARPKD in Adults

Journal of the American Society of Nephrology, 2021
Meenakshi Sambharia   +2 more
openaire   +1 more source

ARPKD

2009
Hubert Scharnagl   +199 more
openaire   +1 more source

Polycystic Kidney Disease: ADPKD and ARPKD

2023
Max Christoph Liebau   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy